Terra Innovatum Global N.V. (NKLR) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to the Terra Innovatum Global fourth quarter fiscal year 2025 strategic business update call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the call, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the call over to your host, Mr. Giordano Moriki, Founding Partner, Chief Business Development Officer, and Director of Investor Relations. Please go ahead, sir. Thanks, Operator, and good morning, everyone. My name is Adelamo Yuki. I'm the Founding Partner and Chief Development Officer and Director of Investor Relations. I'll turn it over to Adelamo. Today, we'll provide a business update on Terranoratum, including recent progress across the solar micro-reactive program, regulatory engagement, commercialization activities, technology development milestones, including the nursing graphite prototype, and key supply chain advancements. For today's call, please note that you can follow along using the accompanying presentation, which is available for full download in the inventory section of Terranoratum's website at terranoratum.com. Before we begin, I want to briefly address planning around our 10K planning. As announced, we anticipate planning in our 10K in the near term as we finalize reporting under a new CFO leadership. Importantly, this does not impact our operations, liquidity, or strategic process and progress, and today's call is focused on substantial business momentum we are seeing across the platform. Further, I want to also discuss something we're seeing on certain data platforms. It was brought to our attention that one of the SEC findin...